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Abstract
AIM: To assess the clinical characteristics of Helicobacter
pylori (H pylori) negative duodenal ulcer.
METHODS: Patients with an endoscopic diagnosis of
duodenal ulcer between 1996 and 2002 were included in
the present study. Patients were considered to be negative
for H pylori, if both histological examination and rapid
urease test of biopsy specimens were negative. A
comparison was made between patients with H pylori
positive and negative duodenal ulcers.
RESULTS: A total of 1 343 patients were studied. Their
mean age was 54.7±0.5 years. There was a male
preponderance (M:F = 2.5:1). Three hundred and ninety-
eight patients (29.6%) did not have H pylori infection.
The annual proportion of patients with H pylori negative
duodenal ulcers increased progressively from 1996 to
2002. On multivariate analysis, patients with H pylori
negative duodenal ulcer were more likely to be older,
have concomitant medical problem, pre-existing malignancy,
recent surgery, underlying sepsis, or taken non-steroidal
anti-inflammatory drugs. In terms of clinical presentations,
patients with H pylori negative duodenal ulcer were more
likely to present with bleeding, multiple ulcers and larger
ulcers.
CONCLUSION: The proportion of patients with H pylori
negative duodenal ulcers is on the rise because of a
continued drop in incidence of H pylori positive duodenal
ulcers in recent years. Such patients have distinct clinical
characteristics and it is important to ascertain the H pylori
status before starting eradication therapy.
© 2005 The WJG Press and Elsevier Inc. All rights reserved.
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INTRODUCTION
Since the first description of Helicobacter pylori (H pylori), infection
with this organism has been considered to be the most important
cause of ulcer disease. Previous studies have reported that
more than 90% and 60% of patients with duodenal ulcer and
gastric ulcer, respectively, were infected with H pylori[1]. The
use of non-steroidal anti-inflammatory drugs (NSAIDs) was
suggested to be the major cause of  the remaining H pylori
negative ulcer disease[1,2]. The prevalence of H pylori infection
in patients with duodenal ulcer was believed to be so high
that confirmatory testing before eradication treatment was
considered unnecessary by some centers[3]. It is now apparent
that the prevalence of H pylori infection in patients with
duodenal ulcer is not as high as what it used to be[4-6].
It is, therefore, important to study the subset of patients
with H pylori negative duodenal ulcer in order to assess any
other etiologic factors associated with ulcer development
and to establish appropriate management strategies. The
present prospective study aimed to compare the differences
between patients with H pylori positive and negative duodenal
ulcer diseases.
MATERIALS AND METHODS
Prospective database
Data from all patients with ulcer disease were prospectively
fed into a computer database. This database contained data
on patients’ demographics, clinical presentations, past history
of ulcer disease, concomitant medical problems, pre-existing
malignancy, recent history of surgery or sepsis, past surgical
history, drug history, family history, social history, vital signs
and results of laboratory investigations on admission, amount
of blood transfusion given, endoscopic findings (including
the location, size and number of lesions), H pylori status,
drug treatment prescribed, endoscopic or surgical therapy
given, and treatment results. All patients presented to the
Department of Surgery, University of Hong Kong Medical
Center at Queen Mary Hospital with a diagnosis of ulcer
disease were included into the database.
Upper endoscopy
Except for those with active gastrointestinal bleeding, patients
were fasted for at least 8 h before endoscopic examination.
Endoscopic examination was performed under local
pharyngeal anesthesia with the patient lying in a left lateral
position. Endoscopic findings were prospectively recorded
into the database. An ulcer was defined as a mucosal defect
not less than 5 mm in at least one direction. Any mucosal
defect of less than 5 mm was classified as erosion. Regardless
of the endoscopic findings, three antral mucosal biopsy
specimens were taken from within 3 cm of the pylorus and
removed from the biopsy forceps (Olympus FB 25K,
Olympus, Japan) with a needle. Two biopsy specimens were
fixed with 40 g/L formaldehyde for histological examination,
while one biopsy specimen was subjected to a rapid urease
test[7]. In patients who have taken a proton pump inhibitor,
an antibiotic, a bismuth compound, or eradication therapy
for H pylori, two additional corpus mucosal biopsy specimens
would be sent for histological examination. Patients were
considered to be negative for H pylori if both histological
examination and rapid urease test were negative. Patients
were considered positive for H pylori if any one of the tests
was positive.
Patients
Patients with an endoscopic diagnosis of duodenal ulcer
between 1996 and 2002 were included in the present study.
Patients were excluded if (1) they failed to provide an
adequate history, including drug history, (2) their H pylori
status was not assessed at the time of presentation, (3) they
have taken an antibiotic, a bismuth compound, or eradication
therapy for H pylori within 3 mo prior to the upper
endoscopy, or (3) they refused upper endoscopy. Patients
who have taken a proton pump inhibitor were not excluded.
Statistical analysis
All continuous values were expressed as mean±SE of mean
unless otherwise stated. Univariate analysis was performed
by Student’s t-test for continuous variables and by 2 test
(with Yates’ correction where appropriate) for categorical
variables. Fisher’s exact test was used if any expected cell
value in a (2×2) table was less than five. Significant factors
identified on univariate analysis were subjected to multivariate
stepwise logistic regression analysis. Data analyses were
performed with a standard biomedical software package
and differences with a P value of less than 0.05 were
regarded as statistically significant.
RESULTS
From January 1996 to December 2002, 1 343 patients
satisfied the inclusion criteria for this study. Their mean
age was 54.7±0.5 years. There was a male preponderance
(M:F = 2.5:1). Their main presentations included pain (249
patients, 18.5%), bleeding (1 074 patients, 80.0%), anemia
(14 patients, 1.0%), and obstruction (6 patients, 0.4%).
Three hundred and fourteen patients (23.4%) were
smokers, while 61 patients (4.5%) were alcoholics. Four
hundred and thirty patients (32.0%) have one or more
concomitant medical problems (Table 1). Of  these 430
patients, 222 have one, 138 have two, 55 have three, 11
have four, and 4 have five concomitant medical problems.
Fifty-five patients (4.1%) gave a past history of pulmonary
tuberculosis.
Sixty-five patients (4.8%) have history of malignancy
either currently or in the past, including colorectal cancer
(13), urological cancer (10), lung cancer (10), gynecological
cancer (8), cancer of nasopharynx (7), breast cancer (5),
cancer of larynx (2), liver cancer (2), thyroid cancer (2),
tongue cancer (1), lymphoma (1), cancer of maxilla (1),
cancer of hypopharynx (1), sarcoma (1), and bone metastasis
(1). Thirty-nine patients (2.9%) have undergone surgery
within 3 mo before presentation. The natures of the
operations are listed in Table 2. Twenty patients (1.5%) have
underlying sepsis at the time of presentation, which included
chest infection (11), intra-abdominal infection (4), urinary
tract infection (3), and orthopedic infection (2). Current
medications taken by the patients included NSAIDs (102),
aspirin (67), corticosteroids (4), H2 blockers (84), and proton
pump inhibitors (15).
Seventy-six patients (5.7%) have multiple ulcers (more
than two ulcers) on presentation. Three hundred and ninety-
eight patients (29.6%) did not have H pylori infection.
Although the annual proportion of patients with H pylori
negative duodenal ulcers increased progressively from 1996
to 2002, the increase was due to an ongoing drop in the
number of patients with H pylori positive duodenal ulcers;
the annual number of patients with H pylori negative
duodenal ulcers has remained relatively constant over the
study period (Figure 1).
We analyzed the differences between H pylori positive
and negative duodenal ulcers in terms of  their pre-existing
factors and their clinical presentations.
Table 1  Concomitant medical problems
Concomitant medical problems      Number of patients (%)
Hypertension 279 (20.8)
Diabetes mellitus 127 (9.5)
Ischemic heart disease    79 (5.9)
Cerebral vascular accidents    62 (4.6)
Rheumatic diseases    54 (4.0)
Chronic obstructive airway disease    34 (2.5)
Congestive heart failure    27 (2.0)
Chronic renal failure    26 (1.9)
Cirrhosis    21 (1.6)
Asthma    18 (1.3)
Table 2  Nature of recent surgery
Type of operation               Number of patients
Orthopedic              12
Cardiothoracic              10
Colorectal              5
Urology              4
Neurosurgery              1
Hepatobiliary              1
Head and neck              1
Vascular              1
Appendicectomy              1
Gynecology              1
Endocrine              1
Ophthalmology              1
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Differences in pre-existing factors
On univariate analysis, patients with H pylori negative
duodenal ulcer were significantly more likely females, older,
having concomitant medical problem, having pre-existing
malignancy, having recent surgery, having underlying
sepsis, taking NSAIDs, taking aspirin, or being non-smokers
(Table 3).
On multivariate analysis, six factors were found to be
independently associated with H pylori negative duodenal
ulcer. These factors included older age, concomitant medical
problem, pre-existing malignancy, recent surgery, underlying
sepsis, and NSAIDs usage (Table 3).
On analyzing the relationship of each concomitant
medical problem with the H pylori status, all except asthma
were significantly associated with H pylori negative duodenal
ulcer (Table 4).
Table 3  Characteristics of patients according to their H pylori status
Characteristics              H pylori negative      H pylori positive       P
   (n = 398)       (n = 945)
Sex (M/F)    268/130       693/252        <0.03
Age (yr)    65.3±0.9       50.3±0.6        <0.0011
Concomitant medical problem (%)         50.8            24.1            <0.0011
Pre-existing malignancy (%)         10.3               2.5           <0.0011
Recent surgery (%)            8.0               0.7           <0.0011
Recent sepsis (%)            5.0               0              <0.0011
NSAIDs usage (%)         13.1               5.3           <0.0011
Aspirin usage (%)            7.3               4.0              0.019
Corticosteroid usage (%)            0.8               0.1              0.08
Smoking (%)         18.1            25.6              0.003
Drinking (%)            3.5               5.0              0.315
1Significant factors on multivariate analysis.
Table 4  Relationship of H pylori status and concomitant medical
problem
Concomitant medical             H pylori negative       H pylori positive P
problem (%)    (n = 398)        (n = 945)
Hypertension         30.7            16.6            <0.001
Diabetes mellitus         15.3               7.0            <0.001
Ischemic heart disease         10.0               4.1            <0.001
Rheumatic diseases            7.8               2.4            <0.001
Cerebral vascular accidents            7.3               3.5            <0.005
Congestive heart failure            5.8               0.4            <0.001
Chronic renal failure            5.8               0.3            <0.001
Chronic obstructive airway disease            5.5               1.3            <0.001
Cirrhosis            4.0               0.5            <0.001
Asthma            1.0               1.5                 NS
Differences in clinical presentations
Patients with H pylori negative duodenal ulcer were more
likely to present with bleeding, multiple ulcers (i.e., more
than two ulcers), and larger ulcers (Table 5).
Table 5  Clinical presentations of patients according to their H pylori
status
Presentations          H pylori negative      H pylori positive               P
(n = 398)               (n = 945)
Presenting symptom
     Pain        59 190
     Bleeding      335 753
     Obstruction         4     2             <0.02
Multiple ulcers (%)        10.6      3.6             <0.001
Ulcer size (cm)  1.2±0.04                0.9±0.02             <0.001
DISCUSSION
Previous studies have reported that more than 90% of
patients with duodenal ulcer are infected with H pylori[1].
The use of NSAIDs was considered as the major cause of
H pylori negative ulcer disease[1,2]. Owing to the high
prevalence of H pylori infection in patients with duodenal
ulcer, patients were given empirical eradication therapy
without confirmatory testing of  the infection in some
centers[3]. Nevertheless, confirmatory testing of  H pylori
status is considered necessary today in view of a rising
prevalence of H pylori negative duodenal ulcer[4-6].
Nowadays it is evident that, apart from H pylori and
NSAIDs usage, there remains a group of patients with ulcers
of  unknown etiology[6]. Besides, there were also arguments
put forward to contend against H pylori as the primary cause
of duodenal ulcer disease. Firstly, it has not fulfilled all
the four Koch’s postulates[8-10]. Secondly, the prevalence of
ulcer disease is far lower than the prevalence of H pylori
infection[9]. Thirdly, the Indians in Fiji have twice the number
of duodenal ulcer than Fijians, although they have similar
prevalence of  H pylori infection[11,12]. Fourthly, there were
numerous recent reports of a rising prevalence of H pylori
negative duodenal ulcer[4,5,12,13]. Fifthly, a meta-analysis of
North American studies revealed a 20% ulcer recurrence
rate within 6 mo of successful eradication of H pylori[14].
The authors concluded that non-H pylori, non-NSAIDS-
related ulcer disease may be more common in the USA
than previously believed[14].
In view of the significant proportion of H pylori negative
duodenal ulcers and the possible existence of causal factors
other than H pylori, it is necessary to study the differences
between H pylori negative and positive ulcers in order to
identify factors other than H pylori, which are involved in
the development of ulcer disease.
In the present prospective study of 1 343 patients with
endoscopically confirmed duodenal ulcer disease, only
70.4% of patients have H pylori infection. A similar
prevalence of H pylori infection in patients with duodenal
ulcer was reported by a number of recent studies[5,15]. In
view of the current prevalence of H pylori infection in
patients with duodenal ulcer, it is important to confirm the
Figure 1  Number of patients diagnosed to have duodenal ulcer with and
without H pylori infection from 1996 to 2002.
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H pylori status before prescribing eradication therapy.
It is clear from the present study that the rising proportion
of H pylori negative duodenal ulcer was due to a progressive
reduction in the number of patients with H pylori positive
duodenal ulcer. This is most likely the result of widespread
adoption of H pylori eradication for the treatment of H pylori
related ulcer both in the primary and in the tertiary care
settings in Hong Kong. The different extent in eradication
of H pylori in different countries may account for the global
variation in the prevalence of H pylori negative duodenal
ulcer. The finding that the number of patients with H pylori
negative duodenal ulcer has remained static suggested that
duodenal ulcer might persist as a health problem unless we
are able to identify other etiologic factors which are
preventable.
H pylori negative duodenal ulcer was found to be associated
with older age, concomitant medical problem, pre-existing
malignancy, recent surgery, underlying sepsis, and NSAIDs
usage. In the past, the majority of H pylori negative duodenal
ulcers was believed to be related to NSAIDs usage[2]. The
present study did confirm that NSAIDs is an independent
factor associated with H pylori negative duodenal ulcer.
However, only about 13% of patients with H pylori negative
duodenal ulcer have taken NSAIDs (Table 3). Stress, as a
result of recent surgical trauma or underlying sepsis, was
also found to be another important risk factor for H pylori
negative duodenal ulcer. In fact, it has been known for
many years that trauma and sepsis are potent risk factors
for the development of ulcer disease[16,17]. Such factors could
therefore result in ulcer disease in the absence of H pylori
infection.
The association of concomitant medical problem with
H pylori negative duodenal ulcer could not be adequately
explained. Apart from asthma, all medical problems were
significantly associated with H pylori negative duodenal ulcer.
Cirrhotic patients were known to have a higher risk of
duodenal ulcer independent of H pylori infection[18]. On the
other hand, patients with chronic renal failure were known
to have a lower rate of H pylori infection[19,20]. The exact
reason why concomitant medical problem is related to
H pylori negative duodenal ulcer remains to be elucidated.
Older age was also found to be associated with H pylori
negative duodenal ulcer in other published studies[13,21].
Physical inactivity was known to be associated with a higher
chance of ulcer disease[22,23]. Whether physical inactivity is
related to the development of duodenal ulcer in elderly
individuals or individuals with underlying medical problem
is currently unknown.
It is noteworthy that H pylori negative duodenal ulcer
more commonly presented with bleeding, with larger ulcer,
or with multiple ulcers. In an elderly patient requiring
emergency surgery for bleeding duodenal ulcer, which is
usually large in size, acid-reduction surgery may need to be
considered in view of the likelihood that the ulcer is unrelated
to H pylori infection.
It is unlikely that risk factors identified for H pylori
negative duodenal ulcer will vanish in the future. In the
presence of an aging population, therefore, it is possible
that duodenal ulcer will persist worldwide even with the
increasing use of eradication therapy and the availability of
more selective COX-2 inhibitors.
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